Study to assess MEDI4736 with either AZD9150 or AZD5069 in advanced solid tumors & relapsed metastatic Squamous cell carcinoma of head & neck

Trial Identifier: D5660C00004
Sponsor: AstraZeneca
Collaborator:
MedImmune Inc.
Start Date: August 2015
Primary Completion Date: February 2020
Study Completion Date: October 2025
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Italian Translation
English Translation
French (Belgium) Translation
Spanish Translation
Spanish (United States) Translation
Belgium Flemish Translation
German Translation

Trial Locations

Country Location
BE Antwerpen, BE, 2020
BE Brussels, BE, 1000
BE Bruxelles, BE, 1200
BE Edegem, BE, 2650
BE Namur, BE, 5000
DE Berlin, DE, 12200
DE Dresden, DE, 1307
DE Frankfurt, DE, 60488
DE Hamburg, DE, 20246
DE Hannover, DE, 30625
DE Jena, DE, 07743
DE Köln, DE, 50670
DE München, DE, 81675
ES Barcelona, ES, 08035
ES Hospitalet deLlobregat, ES, 08907
ES Madrid, ES, 28040
ES Madrid, ES, 28041
ES Toledo, ES, 45004
GB Birmingham, GB, B15 2TH
GB London, GB, SW3 6JB
GB London, GB, SE1 9RT
GB Manchester, GB, M20 4BX
GB Surrey, GB, SM2 5PT
GB Taunton, GB, TA1 5DA
IT Milano, IT, 20133
US, AL Birmingham, AL, US, 35294
US, CA Duarte, CA, US, 91010
US, CA La Jolla, CA, US, 92093
US, CA Los Angeles, CA, US, 90089
US, CA Los Angeles, CA, US, 90024
US, CA Orange, CA, US, 92868-3298
US, CA San Francisco, CA, US, 94158
US, CO Denver, CO, US, 80218
US, FL Plantation, FL, US, 33324
US, FL Sarasota, FL, US, 34232
US, IN Lafayette, IN, US, 47905
US, MA Boston, MA, US, 02111
US, MI Detroit, MI, US, 48201
US, MT Billings, MT, US, 59101
US, NJ Morristown, NJ, US, 07960
US, OH Cincinnati, OH, US, 45267-2827
US, TX Houston, TX, US, 77030
US, VA Fairfax, VA, US, 22031
US, WA Seattle, WA, US, 98109